COSCIENS Biopharma News

HC Wainwright & Co. Maintains Buy on AEterna Zentaris, Lowers Price Target to $15

BenzingaNov 13, 2023 11:23 ET

AEterna Zentaris Analyst Ratings

BenzingaNov 13, 2023 11:21 ET

Analysts Offer Insights on Healthcare Companies: Omega Therapeutics (OMGA), Esperion (ESPR) and Aeterna Zentaris (AEZS)

TipRanksNov 13, 2023 06:30 ET

AEterna Zentaris Analyst Ratings

BenzingaAug 10, 2023 07:46 ET

H.C. Wainwright Keeps Their Buy Rating on Aeterna Zentaris (AEZS)

TipRanksAug 10, 2023 06:35 ET

Analysts Offer Insights on Healthcare Companies: Aeterna Zentaris (AEZS) and Alnylam Pharma (ALNY)

TipRanksJul 14, 2023 06:30 ET

HC Wainwright & Co. Reiterates Buy on AEterna Zentaris, Maintains $28 Price Target

BenzingaJul 14, 2023 06:14 ET

AEterna Zentaris Analyst Ratings

BenzingaJul 14, 2023 06:13 ET

H.C. Wainwright Reaffirms Their Buy Rating on Aeterna Zentaris (AEZS)

TipRanksMay 12, 2023 06:25 ET

Analysts Offer Insights on Healthcare Companies: Timber Pharmaceuticals (TMBR), Aeterna Zentaris (AEZS) and Cabaletta Bio (CABA)

TipRanksApr 10, 2023 06:21 ET

HC Wainwright & Co. Reiterates Buy on AEterna Zentaris, Maintains $28 Price Target

BenzingaApr 10, 2023 06:20 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Aeterna Zentaris (AEZS), Delcath Systems (DCTH) and GlaxoSmithKline (GSK)

TipRanksMar 28, 2023 06:38 ET

HC Wainwright & Co. Reiterates Buy on AEterna Zentaris, Maintains $28 Price Target

BenzingaMar 28, 2023 06:35 ET

Analysts Offer Insights on Healthcare Companies: Aeterna Zentaris (AEZS), Arrowhead Pharmaceuticals (ARWR) and Enlivex (ENLV)

TipRanksJan 23, 2023 06:25 ET

H.C. Wainwright Reaffirms Their Buy Rating on Aeterna Zentaris (AEZS)

TipRanksSep 6, 2022 06:20 ET

H.C. Wainwright Sticks to Its Buy Rating for Aeterna Zentaris (AEZS)

TipRanksAug 8, 2022 06:30 ET

Analysts Are Bullish on Top Healthcare Stocks: Aeterna Zentaris (AEZS), Portage Biotech Inc (PRTG)

TipRanksJul 8, 2022 06:30 ET